The Lund Stem Cell Centre researchers have been awarded a 5-year grant from Vinnova. Vinnova is Sweden’s innovation agency with the mission to build up Sweden’s innovation capacity. Earlier this year they announced a call for projects aimed at establishing “Innovative Environments for Precision Medicine” and last week they announced that the Lund-based IndiCell project is one of the funded projects.
IndiCell is a collaborative project designed to link academia, hospitals and industry to generate a workflow from academic stem cell research into the clinic. The project has a strong focus on individualised stem cell-based cell therapy, with Parkinson’s disease and macular degeneration as examples. IndiCell was funded with 40 million SEK over 5 years and is coordinated by Anna Falk (LU), with Malin Parmar (LU) and Fredrik Lanner (KI) as coordinators and includes partners from Lund University (LU), Karolinska Institutet (KI) ), Royal Institute of Technology (KTH), Skåne University Hospital, Karolinska Hospital, Biolamina, Acousort AB and MAGic BioProcessing.
